Unknown

Dataset Information

0

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model.


ABSTRACT: Alzheimer's disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model was shown to evoke a sequence of immune responses that lead to disease modification. Here, blocking PD-L1, a PD-1 ligand, was found to have similar efficacy to that of PD-1 blocking in disease modification, in both animal models of AD and of tauopathy. Targeting PD-L1 in a tau-driven disease model resulted in increased immunomodulatory monocyte-derived macrophages within the brain parenchyma. Single cell RNA-seq revealed that the homing macrophages expressed unique scavenger molecules including macrophage scavenger receptor 1 (MSR1), which was shown here to be required for the effect of PD-L1 blockade in disease modification. Overall, our results demonstrate that immune checkpoint blockade targeting the PD-1/PD-L1 pathway leads to modification of common factors that go awry in AD and dementia, and thus can potentially provide an immunotherapy to help combat these diseases.

SUBMITTER: Rosenzweig N 

PROVIDER: S-EPMC6349941 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2019-04-18 | GSE130008 | GEO
| PRJNA533562 | ENA
| S-EPMC6209395 | biostudies-literature
| S-EPMC4497957 | biostudies-literature
| S-EPMC5290437 | biostudies-literature
| S-EPMC6380009 | biostudies-literature
| S-EPMC10063777 | biostudies-literature
| S-EPMC6136863 | biostudies-other
| S-EPMC7596316 | biostudies-literature
| S-EPMC5360064 | biostudies-literature